A Music Therapy Study for Blood Cancer Survivors With Cognitive Difficulties
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorMemorial Sloan Kettering Cancer Center
About this trial
Research has shown that music-based activities may help improve brain functions, such as attention, memory, and executive function. Because of this past research, the researchers are doing this study to find out whether telehealth music therapy is a practical treatment for cognitive difficulties in blood cancer survivors. The researchers will also study whether music therapy and music education help improve cognitive function and other common symptoms such as anxiety, depression, and/or tiredness.
Eligibility criteria
This trial accepts healthy volunteersQualifiers
English-proficient, aged 18 or older
Diagnosis of lymphoma, leukemia, or myeloma
Stable oncologic disease or no evidence of disease as indicated in the medical chart or by the oncology team
Score of <54 on the FACT-Cog PCI subscale
Disqualifiers
Less than 3 months since completion of surgery, radiation, induction chemotherapy (for newly diagnosed or relapsed disease), transplantation, or immunotherapy (e.g., CAR T-Cell, bispecific antibodies)
If there is a defined treatment period, the patient must be at least 3 months from treatment completion
If the patient is on continuous therapy, patient must have completed at least 6 months of the therapy
Maintenance therapies are allowed
Trial design
Design model
Parallel
Treatments tested in this trial
Music Therapy/MT
Other interventionTherapeutic music lessons are the core component of the Music Therapy/MT intervention. Other components include guided music listening to help participants use music as a tool for regulating mood, energy, and attention, as well as music-centered discussions to help participants discover songs with personal meaning that they will enjoy learning to play.
Therapist-Attention Music Education/TAME Control
Other interventionParticipants will receive 12, weekly 60-minute TAME sessions (+/- 1 week) with homework in-between sessions to reinforce in-session concepts and serve as transitions to subsequent sessions. The TAME control group will involve board-certified music therapists guiding participants through music listening exercises.
Treatment groups
60 Participants
are divided into 3 treatment groupsGroup A: Music Therapy/MTExperimental treatment 1 intervention
Group B: Therapist Attention-Music Education/TAME controlActive comparator 1 intervention
Group C: Wait-List Control/WLCNo intervention 0 interventions
Trial outcomes
Primary outcomes
1
Feasibility of studying a telehealth-based Music Therapy/MT intervention for cancer-related cognitive dysfunction/CRCD in hematologic cancer survivors as defined as the completion of 9 or more sessions.
The primary objective of this study is to determine the feasibility of studying a telehealth-based Music Therapy/MT intervention for cancer-related cognitive dysfunction/CRCD in hematologic cancer survivors. Feasibility will be defined as the completion of 9 or more sessions out of the planned 12 weekly sessions of music therapy.
Time frame
up to 1 yearSponsors and contacts
Click on the lead sponsor to view all of their trials.
Source ClinicalTrials.gov